文献速递炎症性肠病

肠内营养与糖皮质激素在儿童克罗恩病中的比较:一项来自epi-IIRN的长期全国性研究

Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long-term nationwide study from the epi-IIRN.
PubMed 文献 · Aliment Pharmacol Ther · 2024-05-14

基于以色列epi-IIRN全国队列(覆盖98%人口),纳入2005-2020年确诊的儿童克罗恩病患者,比较肠内营养(EEN)与糖皮质激素作为诱导治疗的长期结局。倾向性评分匹配274例儿童后,糖皮质激素组在0.5、3、5年复杂病程概率、激素依赖和住院率均高于EEN组,但手术、生物制剂使用和生长方面无优势。

要点

  • 匹配后糖皮质激素组0.5、3、5年复杂病程概率分别为14%、42%、54%,EEN组为4%、27%、41%(p=0.0066)。
  • 糖皮质激素组激素依赖(10% vs 2%、15% vs 3%、20% vs 5%,p=0.00018)和住院率(20% vs 11%、37% vs 26%、55% vs 38%,p=0.002)均高于EEN组。
  • EEN在手术生存概率、生物制剂使用和生长方面对比糖皮质激素无优势。

核心结论

  • 儿童克罗恩病使用EEN诱导治疗与较低的长期激素依赖和住院风险相关,结果可能支持优先选择营养治疗。

研究设计与样本

  • 全国性队列研究,数据来自epi-IIRN队列,覆盖98%以色列人口,纳入2005-2020年确诊的儿童克罗恩病患者。
  • 共纳入410例接受EEN和375例接受糖皮质激素且无其他治疗的儿童,中位随访4.73年(IQR:2.2-7.2年,共1433患者年)。
  • 采用倾向性评分个体匹配,匹配后274例儿童用于主要分析。

主要发现

  • 匹配儿童中,糖皮质激素组0.5、3、5年复杂病程概率分别为14%、42%、54%,EEN组分别为4%、27%、41%(p=0.0066)。
  • 糖皮质激素组激素依赖在0.5、3、5年分别为10%、15%、20%,EEN组分别为2%、3%、5%(p=0.00018)。
  • 糖皮质激素组住院率在0.5、3、5年分别为20%、37%、55%,EEN组分别为11%、26%、38%(p=0.002)。
  • 两组生物制剂使用相似。
  • EEN诱导在手术生存概率、生物制剂使用和生长方面对比糖皮质激素无优势。

临床怎么用

  • 原文结论认为这些结果可能支持在儿童克罗恩病中优先选择营养治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both corticosteroids and exclusive enteral nutrition (EEN) have been used as induction therapy in children with Crohn's disease (CD). AIM: To compare in a nationwide study the long-term outcomes of children with CD receiving either EEN or corticosteroids as induction therapy. METHODS: We retrieved data of all children diagnosed with CD (2005-2020) from the epi-IIRN cohort covering 98% of the Israeli population. The primary outcome was time to complicated disease course (i.e., surgery, steroid-dependency, or at least 2 biologic class). Patients were matched individually utilising propensity score adjustments. RESULTS: We included 410 children treated with EEN and 375 with corticosteroids without other treatments (median follow-up, 4.73 [IQR: 2.2-7.2] years [1433 patient-years]). For 274 matched children, the probability of a complicated course was higher with corticosteroids than EEN at 0.5, 3 and 5 years (14% vs. 4%, 42% vs. 27% and 54% vs. 41%, respectively, p = 0.0066), despite similar use of biologics. Steroid-dependency (10% vs. 2%, 15% vs. 3%, and 20% vs. 5%, respectively, p = 0.00018), and hospitalisations (20% vs. 11%, 37% vs. 26%, and 55% vs. 38%, respectively, p = 0.002) were higher with corticosteroids. During follow-up, children receiving corticosteroids as induction treatment were more often further exposed to corticosteroids, and those on EEN were more often further exposed to nutritional treatment (p < 0.001). Induction with EEN had no advantage over corticosteroids regarding survival probability of surgeries, biologic use and growth. CONCLUSIONS: EEN in paediatric CD is associated with lower long-term risks of corticosteroid dependency and hospitalisation than corticosteroids. These results may lend support to favouring nutritional therapy in paediatric CD.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Plotkin L, Buchuk R, Lujan R, et al. Enteral nutrition compared with corticosteroids in children with Crohn's disease: A long-term nationwide study from the epi-IIRN. Aliment Pharmacol Ther. 2024. PMID: 38742605. doi:10.1111/apt.18028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。